For example, in breast cancer, RNF168 has been demonstrated to promote K48-linked ubiquitination of FOXM1, targeting it for proteasomal degradation, consequently enhancing cancer cell sensitivity to doxorubicin-class chemotherapeutic agents [44]. This evidence concerns the gene RNF168 and breast carcinoma.